Empowered Funds LLC Purchases 46,928 Shares of Kenvue Inc. $KVUE

Key Points

• Empowered Funds LLC increased its stake in Kenvue Inc. by 26.4% during the first quarter, acquiring an additional 46,928 shares, bringing its total holdings to 224,937 shares, worth approximately $5.39 million.
• Kenvue recently reported quarterly earnings of $0.29 EPS, surpassing estimates, but its revenue fell 4.0% year-over-year to $3.84 billion, with FY 2025 guidance set at 1.000-1.050 EPS.
• The stock's recent dividend increased to $0.2075 per share, with a yield of 4.4%, while the payout ratio stands at 112.16%.

Empowered Funds LLC boosted its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 26.4% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 224,937 shares of the company's stock after buying an additional 46,928 shares during the quarter. Empowered Funds LLC's holdings in Kenvue were worth $5,394,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Evergreen Wealth Solutions LLC raised its holdings in Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock valued at $402,000 after buying an additional 432 shares during the last quarter. Fulton Bank N.A. raised its holdings in Kenvue by 0.6% during the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock valued at $1,892,000 after buying an additional 465 shares during the last quarter. Scott & Selber Inc. raised its holdings in Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after buying an additional 475 shares during the last quarter. Wealth Alliance LLC raised its holdings in Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after buying an additional 486 shares during the last quarter. Finally, Everett Harris & Co. CA raised its holdings in Kenvue by 1.4% during the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock valued at $887,000 after buying an additional 500 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Evercore ISI lowered their price target on shares of Kenvue from $25.00 to $23.00 and set an "in-line" rating for the company in a report on Monday. Canaccord Genuity Group lowered their price target on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a report on Friday, August 8th. Bank of America decreased their price objective on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, July 15th. Barclays decreased their price objective on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, July 15th. Finally, Citigroup decreased their price objective on shares of Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a report on Tuesday, July 15th. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Kenvue has a consensus rating of "Hold" and an average price target of $24.21.

Kenvue Stock Performance

Shares of KVUE stock opened at $18.84 on Friday. Kenvue Inc. has a one year low of $17.15 and a one year high of $25.17. The company's 50-day moving average is $21.18 and its 200 day moving average is $22.27. The company has a market capitalization of $36.16 billion, a price-to-earnings ratio of 25.46, a price-to-earnings-growth ratio of 2.65 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The company had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same period in the prior year, the firm posted $0.32 EPS. Kenvue's revenue for the quarter was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This is a positive change from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue's payout ratio is currently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.